Sectoral Asset Management Inc Ptc Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

  • $99.8 Million
  • Q4 2024

A detailed history of Sectoral Asset Management Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 5,800 shares of PTCT stock, worth $279,502. This represents 0.26% of its overall portfolio holdings.

Number of Shares
5,800
Previous 7,600 23.68%
Holding current value
$279,502
Previous $281,000 7.12%
% of portfolio
0.26%
Previous 0.23%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$34.99 - $52.07 $62,982 - $93,726
-1,800 Reduced 23.68%
5,800 $261,000
Q3 2024

Nov 14, 2024
BUY
$30.39 - $37.66 $100,287 - $124,277
3,300 Added 76.74%
7,600 $281,000
Q2 2024

Aug 13, 2024
BUY
$24.69 - $40.12 $106,167 - $172,516
4,300 New
4,300 $131,000
Q3 2023

Nov 14, 2023
SELL
$22.41 - $41.99 $1 Million - $1.88 Million
-44,680 Reduced 19.28%
187,016 $4.19 Million
Q2 2023

Aug 11, 2023
BUY
$40.4 - $59.1 $207,252 - $303,183
5,130 Added 2.26%
231,696 $9.42 Million
Q1 2023

May 12, 2023
SELL
$38.16 - $48.86 $35,298 - $45,195
-925 Reduced 0.41%
226,566 $11 Million
Q4 2022

Feb 10, 2023
SELL
$33.53 - $54.79 $382,242 - $624,606
-11,400 Reduced 4.77%
227,491 $8.68 Million
Q3 2022

Nov 10, 2022
SELL
$41.85 - $53.85 $42,561 - $54,765
-1,017 Reduced 0.42%
238,891 $12 Million
Q2 2022

Aug 15, 2022
SELL
$25.6 - $45.23 $626,764 - $1.11 Million
-24,483 Reduced 9.26%
239,908 $9.61 Million
Q1 2022

May 10, 2022
BUY
$33.33 - $44.6 $69,993 - $93,660
2,100 Added 0.8%
264,391 $9.86 Million
Q4 2021

Feb 11, 2022
BUY
$35.36 - $41.86 $353,600 - $418,600
10,000 Added 3.96%
262,291 $10.4 Million
Q3 2021

Nov 15, 2021
SELL
$37.01 - $44.74 $2.96 Million - $3.58 Million
-80,000 Reduced 24.08%
252,291 $9.39 Million
Q2 2021

Aug 16, 2021
SELL
$37.95 - $49.37 $6.55 Million - $8.52 Million
-172,637 Reduced 34.19%
332,291 $14 Million
Q1 2021

May 14, 2021
SELL
$46.8 - $68.92 $4.64 Million - $6.83 Million
-99,050 Reduced 16.4%
504,928 $23.9 Million
Q4 2020

Feb 12, 2021
SELL
$47.96 - $67.64 $3.15 Million - $4.44 Million
-65,600 Reduced 9.8%
603,978 $36.9 Million
Q3 2020

Nov 13, 2020
BUY
$45.41 - $57.07 $6.76 Million - $8.5 Million
148,911 Added 28.6%
669,578 $31.3 Million
Q2 2020

Aug 13, 2020
BUY
$42.56 - $54.98 $9.44 Million - $12.2 Million
221,823 Added 74.23%
520,667 $26.4 Million
Q1 2020

May 13, 2020
SELL
$32.37 - $59.36 $967,668 - $1.77 Million
-29,894 Reduced 9.09%
298,844 $13.3 Million
Q4 2019

Feb 12, 2020
SELL
$32.22 - $50.07 $1.56 Million - $2.43 Million
-48,500 Reduced 12.86%
328,738 $15.8 Million
Q3 2019

Nov 14, 2019
SELL
$33.82 - $48.17 $2.48 Million - $3.54 Million
-73,400 Reduced 16.29%
377,238 $12.8 Million
Q2 2019

Aug 14, 2019
SELL
$35.42 - $45.0 $442,714 - $562,455
-12,499 Reduced 2.7%
450,638 $20.3 Million
Q1 2019

May 14, 2019
BUY
$28.09 - $39.49 $6.45 Million - $9.07 Million
229,601 Added 98.32%
463,137 $17.4 Million
Q4 2018

Feb 12, 2019
BUY
$29.83 - $46.51 $873,989 - $1.36 Million
29,299 Added 14.35%
233,536 $8.02 Million
Q3 2018

Nov 14, 2018
BUY
$33.9 - $47.77 $2.32 Million - $3.27 Million
68,353 Added 50.3%
204,237 $9.6 Million
Q2 2018

Aug 13, 2018
SELL
$25.7 - $47.88 $7.76 Million - $14.5 Million
-302,050 Reduced 68.97%
135,884 $4.58 Million
Q1 2018

May 15, 2018
BUY
$17.46 - $32.59 $1.14 Million - $2.13 Million
65,300 Added 17.52%
437,934 $11.9 Million
Q4 2017

Feb 13, 2018
BUY
$15.14 - $20.89 $3.06 Million - $4.22 Million
202,099 Added 118.51%
372,634 $6.22 Million
Q3 2017

Nov 14, 2017
BUY
$16.81 - $21.61 $2.87 Million - $3.69 Million
170,535
170,535 $3.41 Million

Others Institutions Holding PTCT

# of Institutions
262
Shares Held
72.6M
Call Options Held
179K
Put Options Held
536K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.45B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email